- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07597954
Reciprocal Mother-Infant Voice Exposure in the Neonatal Intensive Care Unit
14. maj 2026 opdateret af: Nilgun Avci, Biruni University
Hearing Each Other: Effects of Reciprocal Maternal-Infant Voice Exposure on Maternal Attachment and Breastfeeding in the NICU: A Randomized Controlled Trial
This randomized controlled trial evaluates the effect of reciprocal maternal-infant voice exposure on maternal attachment and breastfeeding outcomes in a neonatal intensive care unit (NICU).
Infants in the intervention group are exposed to recordings of their mothers' voices, while mothers simultaneously listen to recordings of their infants' sounds between the 6th and 12th postpartum hours.
The intervention is administered every 2 hours for 30 minutes.
Outcomes include maternal attachment, breastfeeding effectiveness, breastfeeding self-efficacy, infant feeding intention, perceived insufficient milk, and expressed breast milk volume.
Neonatal physiological parameters and blood gas values are also assessed.
The findings aim to support family-centered NICU care through non-invasive auditory interventions.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
60
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Istanbul, Tyrkiet (Türkiye)
- Nilgün Avcı
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Mothers aged ≥18 years
- Infants ≥37 weeks gestation
- Diagnosis of transient tachypnea of the newborn (TTN)
- Infant admitted to NICU ≥6 hours
- Ability to communicate in Turkish
Exclusion Criteria:
- Infant clinical deterioration requiring transfer
- Maternal psychiatric disorder
- Hearing impairment
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Reciprocal Voice Exposure Group
Reciprocal auditory stimulation consisting of maternal voice recordings played to infants and infant sound recordings played to mothers every 2 hours for 30 minutes between the 6th and 12th postpartum hours.
|
Reciprocal auditory stimulation consisting of maternal voice recordings played to infants and infant sound recordings played to mothers every 2 hours for 30 minutes between the 6th and 12th postpartum hours.
|
|
Ingen indgriben: Routine Care Group
Standard NICU care without auditory stimulation.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Maternal Attachment
Tidsramme: 12th postpartum hour
|
Measured using the Maternal Attachment Inventory (26 items; scores range from 26 to 104; higher scores indicate stronger attachment).
|
12th postpartum hour
|
|
Breastfeeding Effectiveness
Tidsramme: 12th postpartum hour
|
Measured using the Bristol Breastfeeding Assessment Tool (scores range from 0 to 8; higher scores indicate more effective breastfeeding).
|
12th postpartum hour
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Breastfeeding Self-Efficacy
Tidsramme: 12th postpartum hour
|
Measured using the Breastfeeding Self-Efficacy Scale-Short Form (14 items; scores range from 14 to 70; higher scores indicate greater self-efficacy).
|
12th postpartum hour
|
|
Infant Feeding Intention
Tidsramme: 12th postpartum hour
|
Measured using the Infant Feeding Intention Scale.
Scores range from 0 to 16; higher scores indicate stronger intention to breastfeed.
|
12th postpartum hour
|
|
Perceived Insufficient Milk
Tidsramme: 12th postpartum hour
|
Measured using the Perceived Insufficient Milk Scale.
Higher scores indicate greater perceived milk insufficiency.
|
12th postpartum hour
|
|
Expressed Breast Milk Volume
Tidsramme: Between 6th and 12th postpartum hours
|
Volume of breast milk expressed using an electric pump, measured in milliliters (mL).
|
Between 6th and 12th postpartum hours
|
|
Neonatal Physiological Parameters
Tidsramme: 6th, 8th, 10th, and 12th postpartum hours
|
Respiratory Rate: Measured in breaths per minute.
|
6th, 8th, 10th, and 12th postpartum hours
|
|
Oxygen Saturation
Tidsramme: 6th, 8th, 10th, and 12th postpartum hours.
|
Peripheral oxygen saturation measured as percentage (%).
|
6th, 8th, 10th, and 12th postpartum hours.
|
|
Heart Rate
Tidsramme: 6th, 8th, 10th, and 12th postpartum hours.
|
Heart rate measured in beats per minute (bpm).
|
6th, 8th, 10th, and 12th postpartum hours.
|
|
Partial Pressure of Oxygen (pO₂)
Tidsramme: Between 6th and 12th postpartum hours.
|
Partial pressure of oxygen measured in mmHg.
|
Between 6th and 12th postpartum hours.
|
|
Partial Pressure of Carbon Dioxide (pCO₂)
Tidsramme: Between 6th and 12th postpartum hours.
|
Partial pressure of carbon dioxide measured in mmHg.
|
Between 6th and 12th postpartum hours.
|
|
Blood pH
Tidsramme: Between 6th and 12th postpartum hours.
|
Blood pH measured as a unitless value.
|
Between 6th and 12th postpartum hours.
|
|
Blood Lactate Level
Tidsramme: Between 6th and 12th postpartum hours.
|
Blood lactate level measured in mmol/L.
|
Between 6th and 12th postpartum hours.
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. oktober 2022
Primær færdiggørelse (Faktiske)
30. september 2023
Studieafslutning (Faktiske)
30. september 2023
Datoer for studieregistrering
Først indsendt
6. maj 2026
Først indsendt, der opfyldte QC-kriterier
14. maj 2026
Først opslået (Faktiske)
20. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
20. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. maj 2026
Sidst verificeret
1. oktober 2022
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Luftvejssygdomme
- Lungesygdomme
- Respirationsforstyrrelser
- Spædbørn, for tidligt fødte, Sygdomme
- Spædbarn, Nyfødt, Sygdomme
- Tegn og symptomer, luftveje
- Respiratory Distress Syndrome, nyfødt
- Respiratory Distress Syndrome
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- Opførsel
- Tegn og symptomer
- Fodringsadfærd
- Takypnø
- Forbigående takypnø hos den nyfødte
- Amning
Andre undersøgelses-id-numre
- Reciprocal Mother-Infant Voice
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .